ScoreComparison
Why is Organogenesis Holdings, Inc. ?
1
High Management Efficiency with a high ROE of 15.16%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0 times
3
Healthy long term growth as Net Sales has grown by an annual rate of 8.73% and Operating profit at -14.19%
4
The company declared very negative results in Mar'25 after very positive results in Dec'24
- NET PROFIT(9M) At USD 3.51 MM has Grown at -78.03%
- OPERATING CASH FLOW(Y) Lowest at USD -38.78 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 4.28 times
5
With ROE of 2.90%, it has a attractive valuation with a 0.86 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -48.50%, its profits have fallen by -35.5%
6
High Institutional Holdings at 59.88%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Below par performance in long term as well as near term
- Along with generating -48.50% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Organogenesis Holdings, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Organogenesis Holdings, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Organogenesis Holdings, Inc.
-48.5%
-0.03
90.53%
S&P 500
18.81%
0.98
19.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.73%
EBIT Growth (5y)
-14.19%
EBIT to Interest (avg)
8.26
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
1.24
Tax Ratio
34.50%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
59.88%
ROCE (avg)
16.10%
ROE (avg)
15.16%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
0.86
EV to EBIT
154.68
EV to EBITDA
9.92
EV to Capital Employed
0.84
EV to Sales
0.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
0.54%
ROE (Latest)
2.90%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
RAW MATERIAL COST(Y)
Fallen by 1.47% (YoY
NET SALES(Q)
Highest at USD 150.86 MM
OPERATING PROFIT(Q)
Highest at USD 29.15 MM
OPERATING PROFIT MARGIN(Q)
Highest at 19.32 %
PRE-TAX PROFIT(Q)
Highest at USD 22.6 MM
NET PROFIT(Q)
Highest at USD 23 MM
EPS(Q)
Highest at USD 0.11
-9What is not working for the Company
NET PROFIT(9M)
At USD 3.51 MM has Grown at -78.03%
OPERATING CASH FLOW(Y)
Lowest at USD -38.78 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.28 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.45 times
Here's what is working for Organogenesis Holdings, Inc.
Pre-Tax Profit
At USD 22.6 MM has Grown at 806.3%
over average net sales of the previous four periods of USD -3.2 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 23 MM has Grown at 17,872.66%
over average net sales of the previous four periods of USD 0.13 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
At USD 150.86 MM has Grown at 40.49%
over average net sales of the previous four periods of USD 107.38 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
Highest at USD 150.86 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 29.15 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 19.32 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 22.6 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 23 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 0.11
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by 1.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 6.99 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Organogenesis Holdings, Inc.
Operating Cash Flow
Lowest at USD -38.78 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Lowest at 4.28 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 3.45 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
